ICL presents nutritional program at the largest banana farming fair in the country
From May 10th to 12th, during FEIBANANA 2022, in Pariquera-Açú (SP), the company will be presenting the Supera Nutritional Program to producers
09.05.2022 | 13:54 (UTC -3)
Claudia Santos
The fourth largest banana producer in the world, behind only India, China and Indonesia, Brazil presented, in 2021, according to IBGE, an estimated national production of 7 million tons in an area of 465,9 thousand hectares.
ICL, which uses its exclusive resources and technological capacity to develop impactful solutions in plant nutrition and physiology, collaborates with the increase of production in the country, offering the sector the Supera Nutritional Program, which includes ICL's best technologies and innovations and has The objective is to promote physiological and nutritional benefits for banana cultivation through soil and foliar nutrition, which allow an increase of up to 15% in banana productivity. The positioning, such as doses and times of application, is determined based on research results, to meet the nutritional and physiological requirements of crops at each phenological stage.
From May 10th to 12th, during FEIBANANA 2022, the largest banana farming fair in the country, in Pariquera-Açú (SP), the company will be presenting the program to producers. “We want to promote sustainable agriculture that increases the productivity, quality and profitability of agribusiness. ICL's Supera Nutritional Program's main objective is to deliver the best technologies and solutions in plant nutrition and physiology. And, in this way, contribute to ensuring that banana plantations are always well nourished and prepared to overcome stress and deliver maximum profitability to the producer. This will be possible because we have the support of agronomic consultants and a team of highly trained professionals, through scheduled visits. And with the offer of a complete portfolio”, declares agricultural engineer Bruno Domingues, Marketing Manager for HF at ICL.